| Announcement Title |
Outcome of Regulatory Review |
| Date & Time of Broadcast |
Feb 25, 2026 22:56 |
| Status |
Replace |
| Corporate Action Reference |
SG251031RHDI4961 |
| Submitted By (Co./ Ind. Name) |
Madan Mohan |
| Designation |
Company Secretary |
| Event Status |
Pending AIP/ LQN Announcement |
| Underwritten |
No |
| Shareholders' Approval Required? |
Yes |
| Shareholders' Approval Obtained |
No |
| Financial Year End |
31/12/2024 |
| Foreign Shareholder Eligibility |
No |
| Attachment for Intent |
20251031 - Anct_for_Revised_Rights_cum_Warrants_Issue.pdf |
|
|
| Regulatory Outcome |
| Attachment For Regulatory Outcome |
|
| 20260225 - AIP Announcement.pdf |
|
| Event Narrative |
| Narrative Type |
Narrative Text |
| Additional Text |
Revision of Terms to the Proposed Renounceable Non-Underwritten Rights cum Warrants Issue |
| Additional Text |
Please refer to the attachment for details. |
| Dates |
| Rights Details |
| Security Not Found? |
No |
| Renounceable |
Yes |
| Rights Security Distribution Ratio- Underlying |
3 |
| Rights Security Distribution Ratio- Rights Security |
5 |
| Option Exercise |
| Issue Price (Per Rights) |
SGD 0.045 |
| Disbursed Security |
| ISIN |
Name |
Security Type |
Distribution Ratio- Rights |
Distribution Ratio- Disbursed |
| SGXE29738106 |
MDR LIMITED |
Common Stock |
1 |
1 |
|
| Renounceable Conditions |
| Allow Over Subscription |
Yes |